MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE

    公开(公告)号:US20250000966A1

    公开(公告)日:2025-01-02

    申请号:US18701156

    申请日:2022-10-13

    Abstract: The present disclosure provides compositions and polynucleotides for increasing expression of an immunogenic and/or antigenic polypeptide (e.g., in a vaccine). The disclosure further provides methods of using the disclosed compositions, polynucleotides, and vaccines for the treatment of diseases and disorders (e.g., infections). The compositions and polynucleotides include a first nucleic acid encoding a viral regulatory protein and a second nucleic acid encoding an immunogenic polypeptide, wherein the immunogenic polypeptide is codon-optimized to a vims from which the regulatory protein is derived.

Patent Agency Ranking